Selective effects of serum on bacterial LPS-induced IL-6 and nitric oxide production in murine peritoneal macrophages
- 1 October 1996
- journal article
- other
- Published by SAGE Publications in Innate Immunity
- Vol. 3 (5) , 395-405
- https://doi.org/10.1177/096805199600300503
Abstract
In lipopolysaccharide (LPS)-dependent activation of human monocytes, the primary function of serum has been thought to provide a source of LPS-binding protein (LBP) for complex formation with LPS preparatory to CD14 binding and initiation of signal transduction. In this report we have investigated the contribution of serum factors in the mouse macrophage response to LPS. Our results show that the production of interleukin-6 (IL-6) by in vitro LPS-stimulated mouse peritoneal macrophages is suppressed in the presence of serum. In contrast, optimal production of nitric oxide (NO) by LPS-stimulated macrophages requires the presence of serum. Detailed kinetic studies indicate that these observations are not exclusively the result of differences in the time course of NO secretion. These findings contrast with equivalent studies carried out using human PBMC, where, under identical conditions of in vitro culture, the presence of serum markedly potentiates LPS-dependent IL-6 production. We have confirmed by RT-PCR, using specific primers for IL-6 and inducible nitric oxide synthase (iNOS), that the effects observed are manifest primarily at the level of mRNA expression. Enhancement of NO responses and suppression of IL-6 responses are both dependent upon serum concentration. These potentiating and inhibiting effects of serum are less apparent with a second microbial stimulus (heat-killed Staphylococcus aureus). Collectively, these results indicate that serum effects on mouse macrophages are multifactorial and, depending upon the particular macrophage response to be measured, can be either enhancing or suppressing. These findings would not, therefore, support the concept of an obligatory role for LBP (and by inference CD14) in the in vitro mouse macrophage response to LPS.Keywords
This publication has 42 references indexed in Scilit:
- Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.The Journal of Experimental Medicine, 1994
- Soluble CD14 participates in the response of cells to lipopolysaccharide.The Journal of Experimental Medicine, 1992
- Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.Journal of Clinical Investigation, 1992
- Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding proteinJournal of Leukocyte Biology, 1992
- Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.The Journal of Experimental Medicine, 1992
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.Proceedings of the National Academy of Sciences, 1986
- Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.The Journal of Experimental Medicine, 1986
- Bacterial Endotoxins and Host Immune ResponsesPublished by Elsevier ,1980